Refractive Status in Children with Laser-Treated Retinopathy of Prematurity: Our Experience in Bulgaria

Authors

  • Nevyana Veleva Eye Clinic, University Hospital "Alexandrovska", Department of Ophthalmology, Medical University, Sofia, Bulgaria
  • Violeta Chernodrinska Eye Clinic, University Hospital "Alexandrovska", Department of Ophthalmology, Medical University, Sofia, Bulgaria

DOI:

https://doi.org/10.3889/oamjms.2019.309

Keywords:

Refraction, ROP, Laser treatment

Abstract

BACKGROUND: With the establishment of laser photocoagulation as a standard treatment modality for prethreshold retinopathy of prematurity (ROP), a dramatic reduction of cases with ROP blindness and severe visual impairment have been reported. In the same time, high refractive errors, a common complication in ROP cases and especially in ROP treated infants, have become the main cause of visual and often severe visual impairment.

AIM: The purpose of our study was to analyse the long-term refractive status in children at 3.5 years after laser-treatment for type 1 prethreshold ROP.

PATIENTS AND METHODS: A retrospective, one centre study of refractive status of 18 children with laser-treated type 1 prethreshold ROP was conducted. The refraction after cycloplegia with 1% cyclopentolate was measured at a mean age of 3.56 years (SD ± 0.34). Hyperopia was subdivided into two groups – low hyperopia (SE < +5.0 D) and high hyperopia (SE ≥ +5.0 D). Myopia was classified as myopia (SE ≥ –0.25D) and high myopia (SE ≥ -5.0 D). Astigmatism was divided into low astigmatism (plus CD ≥ +1.0 D) and high astigmatism (plus CD ≥ +2.0 D).

RESULTS: Thirty-three eyes of 18 children were recruited in the study. Three eyes were excluded because of unfavourable anatomical results. The mean gestational age at birth was 27.3 weeks (24-31 weeks, SD ± 1.78), and the mean birth weight – 928.9 g (550-1500 g, SD ± 252.8). The mean spherical equivalent for the whole group was -1.82 D and ranged from -9.00 D to +4.50 D (SD ± 3.48). Hyperopia was observed in 12 (36.4%) eyes. Myopic refraction had 21 (63.6%) eyes. Astigmatism was detected in 18 (54.5%) eyes. Anisometropia had 3 (16.7%) children. Six children (33.4%) had strabismus (4 esotropia; 2 exotropia).

CONCLUSION: High per cent of treated infants for vision-threatening ROP have visual significant refractive errors and strabismus that can cause serious visual impairment if not treated properly and on time.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Gilbert C, Foster A. Childhood blindness in the context of VISION 2020--the right to sight. Bull World Health Organ. 2003; 79(3):227-232.

Mladenov O. Dynamics of Retinal Changes in Premature Babies. PhD work, Sofia, 2016.

Marinov V, Sivkova N, Krasteva M, Simitchiev K. Visual and refractive outcome after 7 years of treatment of type 1 prethreshold ROP in Plovdiv region. SOE 2017, Barcelona, Spain, 2017. Abstract book.

Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicentre trial of cryotherapy for retinopathy of prematurity. 3.5 year outcome-structure and function. Arch Ophthalmol. 1993; 111:339-44. https://doi.org/10.1001/archopht.1993.01090030057039

Quinn GE, Dobson V, Davitt BV, et al. Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age. J AAPOS. 2013; 17(2):124-128. https://doi.org/10.1016/j.jaapos.2012.10.025 PMid:23622444 PMCid:PMC3725578

Davitt BV, Quinn GE, Wallace DK, et al. Astigmatism progression in the early treatment for retinopathy of prematurity study to 6 years of age. Ophthalmology. 2011; 118(12):2326-2329. https://doi.org/10.1016/j.ophtha.2011.06.006 PMid:21872933 PMCid:PMC3227788

Stoica F, Ladariu C, Koos MJ, et al. Refractive and Visual Outcome after Laser-Treated Retinopathy of Prematurity in Western Romania. Maedica (Buchar). 2016; 11(2):122-129.

Dimitrova-Grozeva E. Retinopathy of Prematurity - regional and national characteristics and contemporary approaches for problem solution. PhD work, Sofia, 2016.

Axer-Siegel R, Maharshak I, Snir M, et al. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes. Retina. 2008; 28(6):839-846. https://doi.org/10.1097/IAE.0b013e318169faee PMid:18536600

Yang CS, Wang AG, Shih YF, et al. Long-term biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age. Acta Ophthalmol Copenh. 2013; 91:276-82. https://doi.org/10.1111/aos.12053 PMid:23601812

Yoon JM, Shin DH, Kim SJ, Ham DI, Kang SW, Chang YS, Park WS. Outcomes after laser versus combined laser and Bevacizumab treatment for type 1 retinopathy of prematurity in zone I. Retina. 2017; 37(1):88-96. https://doi.org/10.1097/IAE.0000000000001125 PMid:27347645

Nguyen PH, Catt C, Nguyen TX, Pham VT. Refractive outcome of prethreshold retinopathy of prematurity treated by diode laser: follow-up at 5 years. Clin Ophthalmol. 2015; 9:1753-1758. https://doi.org/10.2147/OPTH.S84077 PMid:26445521 PMCid:PMC4590667

Katoch D, Sanghi G, Dogra MR, Beke N, Gupta A. Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes. Indian J Ophthalmol. 2011; 59(6):423-426. https://doi.org/10.4103/0301-4738.86306 PMid:22011484 PMCid:PMC3214410

Roohipoor R, Karkhaneh R, Riazi Esfahani M, Alipour F, Haghighat M, et al. Comparison of Refractive Error Changes in Retinopathy of Prematurity Patients Treated with Diode and Red Lasers. Ophthalmologica. 2016; 235(3):173-8. https://doi.org/10.1159/000443844 PMid:26915028

Dhawan A, Dogra M, Vinekar A, Gupta A, Dutta S. Structural sequelae and Refractive outcome after successful laser treatment for Threshold ROP. J Pediatr Ophthalmol Strabismus. 2008; 45:356-61. https://doi.org/10.3928/01913913-20081101-02 PMid:19043947

Vanderveen DK, Coats DK, Dobson V, Fredrick D, Gordon RA, Hardy RJ, et al. Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity: Findings from the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol. 2006; 124:766-73. https://doi.org/10.1001/archopht.124.6.766 PMid:16769828

Sahni J, Subhedar NV, Clark D. Treated threshold stage 3 versus spontaneously regressed subthreshold stage 3 retinopathy of prematurity: a study of motility, refractive, and anatomical outcomes at 6 months and 36 months. Br J Ophthalmol. 2005; 89(2):154-159. https://doi.org/10.1136/bjo.2004.045815 PMid:15665344 PMCid:PMC1772499

Connolly BP, Ng EY, McNamara JA, Regillo CD, Vander JF, Tasman W. Comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: Part 2. refractive outcome. Ophthalmology. 2002; 109:936-41. https://doi.org/10.1016/S0161-6420(01)01015-6

Kuo HK, Sun IT, Chung MY, Chen YH. Refractive Error in Patients with Retinopathy of Prematurity after Laser Photocoagulation or Bevacizumab Monotherapy. Ophthalmologica. 2015; 234(4):211-7. https://doi.org/10.1159/000439182 PMid:26393895

Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA, et al. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol. 2014; 132:1327-33. https://doi.org/10.1001/jamaophthalmol.2014.2772 PMid:25103848

Kuo HK, Sun IT, Chung MY, Chen YH. Refractive error in patients with retinopathy of prematurity after laser photocoagulation or Bevacizumab Monotherapy. Ophthalmologica. 2015; 234:211-217. https://doi.org/10.1159/000439182 PMid:26393895

Lolas M, Tuma A, Zanolli M, Agurto R, Stevenson R, Ossandon D. Anatomical and refractive outcomes in patients with treated retinopathy of prematurity. Arch Soc Esp Oftalmol. 2017; 92(10):472-476. https://doi.org/10.1016/j.oftal.2016.12.007 PMid:28624314

Hwang CK, Hubbard GB, Hutchinson AK, Lambert SR. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis. Ophthalmology. 2015; 122(5):1008-1015. https://doi.org/10.1016/j.ophtha.2014.12.017 PMid:25687024 PMCid:PMC4414677

Kieselbach GF, Ramharter A, Baldissera I, Kralinger MT. Laser photocoagulation for retinopathy of prematurity: structural and functional outcome. Acta Ophthalmol Scand. 2006; 84(1):21-6. https://doi.org/10.1111/j.1600-0420.2005.00548.x PMid:16445435

Yang CS, Wang AG, Sung CS, et al. Long-term visual outcomes of laser-treated threshold retinopathy of prematurity: a study of refractive status at 7 years. Eye Lond Engl. 2010; 24:14-20. https://doi.org/10.1038/eye.2009.63

Kaur S, Sukhija J, Katoch D, Sharma M, Samanta R, Dogra MR. Refractive and ocular biometric profile of children with a history of laser treatment for retinopathy of prematurity. Indian Journal of Ophthalmology. 2017; 65(9):835-840. https://doi.org/10.4103/ijo.IJO_872_16 PMid:28905827 PMCid:PMC5621266

Published

2019-04-30

How to Cite

1.
Veleva N, Chernodrinska V. Refractive Status in Children with Laser-Treated Retinopathy of Prematurity: Our Experience in Bulgaria. Open Access Maced J Med Sci [Internet]. 2019 Apr. 30 [cited 2024 May 2];7(8):1320-3. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2019.309

Issue

Section

B - Clinical Sciences